Skip to content
10-Q

Quarterly Report

Atea Pharmaceuticals, Inc. AVIR

0000950170-25-105123

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 79.36M sh
Shares Diluted Q2 2025 · Jun 30, 2025 83.75M sh
Shares Diluted Q2 2025 · Jun 30, 2025 84.45M sh
Shares Diluted Q2 2025 · Jun 30, 2024 84.25M sh
Shares Diluted Q2 2025 · Jun 30, 2024 84.07M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $14.09M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$63.43M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$82.07M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $87.72M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $64.7M
Stockholders Equity Q2 2025 · Jun 30, 2025 $364.42M
Stockholders Equity Q2 2025 · Mar 31, 2025 $411.08M
Stockholders Equity Q2 2025 · Dec 31, 2024 $438.87M
Stockholders Equity Q2 2025 · Jun 30, 2024 $476.47M
Stockholders Equity Q2 2025 · Mar 31, 2024 $504.37M
Stockholders Equity Q2 2025 · Dec 31, 2023 $555.19M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.12M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.6M
Total Liabilities Q2 2025 · Jun 30, 2025 $27.19M
Total Liabilities Q2 2025 · Dec 31, 2024 $25.8M
Current Assets Q2 2025 · Jun 30, 2025 $385.6M
Current Assets Q2 2025 · Dec 31, 2024 $462.36M
Total Assets Q2 2025 · Jun 30, 2025 $391.61M
Total Assets Q2 2025 · Dec 31, 2024 $464.67M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.44
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.85
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.48
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.44
Eps Basic Q2 2025 · Jun 30, 2025 −$0.85
Eps Basic Q2 2025 · Jun 30, 2024 −$0.48
Eps Basic Q2 2025 · Jun 30, 2024 −$1.23
Sga Expense Q2 2025 · Jun 30, 2025 $9.07M
Sga Expense Q2 2025 · Jun 30, 2025 $18.53M
Sga Expense Q2 2025 · Jun 30, 2024 $12.22M
Sga Expense Q2 2025 · Jun 30, 2024 $24.45M
Rd Expense Q2 2025 · Jun 30, 2025 $32.28M
Rd Expense Q2 2025 · Jun 30, 2025 $61.86M
Rd Expense Q2 2025 · Jun 30, 2024 $34.7M
Rd Expense Q2 2025 · Jun 30, 2024 $92.27M
Net Income Q2 2025 · Jun 30, 2025 −$37.16M
Net Income Q2 2025 · Jun 30, 2025 −$71.43M
Net Income Q2 2025 · Mar 31, 2025 −$34.27M
Net Income Q2 2025 · Jun 30, 2024 −$40.52M
Net Income Q2 2025 · Jun 30, 2024 −$103.69M
Net Income Q2 2025 · Mar 31, 2024 −$63.17M
Operating Income Q2 2025 · Jun 30, 2025 −$41.35M
Operating Income Q2 2025 · Jun 30, 2025 −$80.39M
Operating Income Q2 2025 · Jun 30, 2024 −$46.92M
Operating Income Q2 2025 · Jun 30, 2024 −$116.72M